CAV1 is recognised as an inhibitor of both cell proliferation and fibrosis and is known to be dysregulated in fibrotic diseases such as systemic sclerosis, pulmonary fibrosis, fibrosing cardiomyopathy, and keloid formation [15], [17], [18]. Here, CAV1 is linked to systemic sclerosis.